Immune system stimulation via adjuvant-mediated activation of innate immunity (N/A)

Immune system stimulation via adjuvant-mediated activation of innate immunity refers to the use of adjuvants to enhance and direct the immune response by stimulating components of the innate immune system. This process is critical for increasing vaccine efficacy, shaping adaptive immunity, and ensuring robust, long-lasting protection against pathogens. Adjuvants activate innate immune pathways, increase the magnitude, breadth, and longevity of specific immune responses, and engage pattern recognition receptors (PRRs) to trigger signaling cascades that result in cytokine/chemokine production, recruitment and maturation of APCs, upregulation of co-stimulatory molecules, enhanced antigen presentation, and migration to lymph nodes for T/B cell activation.

Other names

Adjuvant-mediated innate immunity activationAdjuvant effectInnate immune stimulation by adjuvants

Adjuvants stimulate innate immune receptors (e.g., TLRs, NLRs, RLRs) on antigen-presenting cells (APCs), leading to cytokine/chemokine production, APC maturation, and enhanced antigen presentation to T and B cells, ultimately boosting adaptive immunity.